A Study in Patients With Advanced Cancers

NCT05320588 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

332

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Advanced Solid Tumor
Cancer
Oncology

Interventions

DRUG: BIO-106
DRUG: Pembrolizumab

Sponsor

BiOneCure Therapeutics Inc.